Table 2.
Groups |
Kidney weight
(g) |
Water intake
(ml) |
Food intake
(g) |
Urine volume
(ml) |
---|---|---|---|---|
Control | 0.184±0.007 | 9.05±0.37 | 5.31±0.18 | 0.666±0.016 |
Vehicle | 0.182±0.004** | 9.40±0.36* | 5.37±0.19** | 0.660±0.018** |
Diabetes | 0.209±0.007## | 10.58±0.31# | 6.66±0.48## | 0.780±0.020## |
Diabetes + myricitrin 1 mg/kg | 0.183±0.006** | 9.10±0.42* | 5.45±0.31** | 0.687±0.023** |
Diabetes + myricitrin 3 mg/kg | 0.185±0.005** | 8.77±0.43* | 5.78±0.13** | 0.700±0.018** |
Diabetes + myricitrin 10 mg/kg | 0.183±0.009** | 8.25±0.32** | 5.68±0.17** | 0.687±0.024** |
Diabetes + myricitrin SLN 1 mg/kg | 0.180±0.006** | 8.50±0.27** | 5.13±0.13*** | 0.650±0.028** |
Diabetes + myricitrin SLN 3 mg/kg | 0.182±0.004* | 8.40±0.41** | 5.01±0.21*** | 0.688±0.023** |
Diabetes + myricitrin SLN 10 mg/kg | 0.187±0.009** | 8.22±0.40** | 4.96±0.33*** | 0.640±0.018*** |
Data are presented as mean±SEM; n=12; #P<0.05, ##P<0.01 and ###P<0.001 compared to the control, *P<0.05, **P<0.01, and ***P<0.001 compared to the diabetes group. SLN: Solid lipid nanoparticle